Chemours (NYSE:CC) Trading Down 9% After Earnings Miss

The Chemours Company (NYSE:CC)’s share price traded down 9% during mid-day trading on Friday following a weaker than expected earnings announcement. The stock traded as low as $10.71 and last traded at $10.6890. 1,019,455 shares traded hands during trading, a decline of 70% from the average session volume of 3,413,517 shares. The stock had previously closed at $11.74.

The specialty chemicals company reported $0.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04). Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%.The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same period in the prior year, the firm earned $0.40 earnings per share. The business’s revenue was down .9% on a year-over-year basis. Chemours has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Friday, November 14th will be given a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend is Friday, November 14th. Chemours’s dividend payout ratio (DPR) is -12.50%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on CC shares. Mizuho reduced their price objective on Chemours from $19.00 to $18.00 and set an “outperform” rating for the company in a report on Thursday, October 16th. Truist Financial upped their target price on Chemours from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Tuesday, September 16th. Weiss Ratings restated a “sell (d)” rating on shares of Chemours in a report on Wednesday, October 8th. UBS Group boosted their price target on shares of Chemours from $17.00 to $21.00 and gave the stock a “buy” rating in a research report on Monday, October 6th. Finally, Royal Bank Of Canada set a $19.00 target price on Chemours and gave the stock an “outperform” rating in a research report on Tuesday, October 14th. Five research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $18.50.

Institutional Investors Weigh In On Chemours

Hedge funds have recently made changes to their positions in the business. Teacher Retirement System of Texas purchased a new position in shares of Chemours in the 1st quarter worth about $798,000. Principal Financial Group Inc. raised its holdings in shares of Chemours by 116.3% in the first quarter. Principal Financial Group Inc. now owns 742,119 shares of the specialty chemicals company’s stock worth $10,041,000 after buying an additional 399,097 shares during the period. Brown Advisory Inc. raised its stake in shares of Chemours by 6.0% during the first quarter. Brown Advisory Inc. now owns 20,874 shares of the specialty chemicals company’s stock valued at $282,000 after acquiring an additional 1,174 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in Chemours by 124.4% during the first quarter. Nisa Investment Advisors LLC now owns 20,187 shares of the specialty chemicals company’s stock valued at $273,000 after acquiring an additional 11,192 shares during the last quarter. Finally, Louisiana State Employees Retirement System raised its stake in shares of Chemours by 69.6% during the 1st quarter. Louisiana State Employees Retirement System now owns 70,400 shares of the specialty chemicals company’s stock valued at $953,000 after buying an additional 28,900 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors.

Chemours Price Performance

The stock has a 50-day moving average price of $14.94 and a 200 day moving average price of $13.21. The firm has a market capitalization of $1.72 billion, a PE ratio of -4.09 and a beta of 1.64. The company has a quick ratio of 0.83, a current ratio of 1.68 and a debt-to-equity ratio of 17.16.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.